Catégories
-
Adhesives
6
Amines
115
Amino Acids
207
Analytical Reagents
750
Antibiotics
270
Bioactive Small Molecules
798
Aroma Chemicals
242
Biochemicals
1142
Boronic Acids
4
Buffers
104
Building Blocks
2162
Carbohydrates
191
Catalysts
117
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
62
Diagnostic Raw Materials
271
Flavours and Fragrance Materials
234
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
31
HPLC Reagents
8
Imidazoles
18
Indoles
48
Inorganic Chemicals
357
Ion-Pair Reagents
23
Ligands
81
Organics
1628
Oxazoles
3
Peptide Reagents
99
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
65
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
885
Salts
308
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
322
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
22
Water Analysis
13
Adenosine-5'-monophosphate disodium salt (AMP)
(41595662 | 4578-31-8)
CAS: | 4578-31-8 |
---|---|
Formule moléculaire: | C10H12N5Na2O7P |
Masse moléculaire: | 391.18 |
Disponibilité: | En stock |
---|---|
Téléchargements: | | |
41595662-25g | 25g | £30.90 | |
Commande en vrac |
41595662-25g | 25g | €43.30 | |
Commande en vrac |
41595662-25g | 25g | $46.40 | |
Commande en vrac |
Fiche de données de sécurité
Certificat d'analyse
Détails du produit
Product Code | 41595662 | ||||
Product Name | Adenosine-5'-monophosphate disodium salt (AMP) | ||||
Categories | Biochemicals Building Blocks Diagnostic Raw Materials | ||||
CAS | 4578-31-8 | ||||
Molecular Formula | C10H12N5Na2O7P | ||||
Molecular Weight | 391.18 | ||||
Storage Details | Ambient | ||||
Harmonised Tariff Code | 29349990 |
Spécifications du produit
Heavy metals | <10ppm | ||||
Storage Temperature | +20 ° C | ||||
Molecular Weight | 391.18 | ||||
Water Content | <26.0% | ||||
UV content | >95.0% | ||||
Appearance | White or off white powder | ||||
HPLC Purity | >98.0% |
Informations sur la sécurité
Pictograms |
|
||||
Signal word | none | ||||
Hazard statements |
|
||||
Precautionary statements |
|